Marksans Pharma Limited (NSE:MARKSANS)

Marksans Pharma Revenue

In the fiscal year ending March 31, 2026, Marksans Pharma had annual revenue of 29.51B INR with 12.51% growth. Marksans Pharma had revenue of 8.56B in the quarter ending March 31, 2026, with 20.84% growth.

• Revenue: 29.51B
• Revenue Growth: +12.51%
• P/S Ratio: 3.58
• Revenue / Employee: 16.04M
• Employees: 1,840
• Market Cap: 105.67B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	29.51B	3.28B	12.51%
Mar 31, 2025	26.23B	4.45B	20.46%
Mar 31, 2024	21.77B	3.25B	17.56%
Mar 31, 2023	18.52B	3.61B	24.23%
Mar 31, 2022	14.91B	1.15B	8.33%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 7, 2026

Data Sources Report a data error